Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program : Bariatric Surgical Risk/Benefit Calculator: 1-year comorbidity remission
Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Clinical calculators can provide patient-personalized estimates of treatment risks and health outcomes. The American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) set out to create a publicly available tool to assess both short-term postoperative risk and long-term benefits for prospective adult patients eligible for 1 of 4 primary bariatric procedures. The calculator is comprised of multiple prediction elements: (1) 30-day postoperative risk, (2) 1-year body mass index projections, and (3) 1-year comorbidity remission.
OBJECTIVES: To assess the performance of the 1-year comorbidity remission prediction feature of the calculator.
SETTING: Not-for-profit organization clinical data registry.
METHODS: MBSAQIP data across 4.5 years from 240,227 total patients indicating at least 1 comorbidity of interest present preoperatively and who had a 1-year follow-up record documenting their comorbidity status were included. Six models were constructed, stratified by the presence of the respective preoperative comorbidity: hypertension, hyperlipidemia, gastroesophageal reflux disease, sleep apnea, non-insulin-dependent diabetes, and insulin-dependent diabetes. A multinomial logistic regression model was used to predict 1-year remission (total, partial, or no remission) of insulin-dependent diabetes. All other outcomes were binary (yes or no at 1 yr), and ordinary logistic regression models were used.
RESULTS: All models showed adequate discrimination (C statistics ranging from .58 to .68). Plots of observed versus predicted remission (%) showed excellent calibration across all models.
CONCLUSION: All remission models were well calibrated with sufficient discrimination. The MBSAQIP Bariatric Surgical Risk/Benefit Calculator is a publicly available tool intended for integration into clinical practice to enhance patient-clinician discussions and informed consent.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery - 20(2024), 3 vom: 31. März, Seite 275-282 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grieco, Arielle [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.soard.2023.09.020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363593713 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363593713 | ||
| 003 | DE-627 | ||
| 005 | 20240301232104.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.soard.2023.09.020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM363593713 | ||
| 035 | |a (NLM)37867047 | ||
| 035 | |a (PII)S1550-7289(23)00708-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grieco, Arielle |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program |b Bariatric Surgical Risk/Benefit Calculator: 1-year comorbidity remission |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Clinical calculators can provide patient-personalized estimates of treatment risks and health outcomes. The American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) set out to create a publicly available tool to assess both short-term postoperative risk and long-term benefits for prospective adult patients eligible for 1 of 4 primary bariatric procedures. The calculator is comprised of multiple prediction elements: (1) 30-day postoperative risk, (2) 1-year body mass index projections, and (3) 1-year comorbidity remission | ||
| 520 | |a OBJECTIVES: To assess the performance of the 1-year comorbidity remission prediction feature of the calculator | ||
| 520 | |a SETTING: Not-for-profit organization clinical data registry | ||
| 520 | |a METHODS: MBSAQIP data across 4.5 years from 240,227 total patients indicating at least 1 comorbidity of interest present preoperatively and who had a 1-year follow-up record documenting their comorbidity status were included. Six models were constructed, stratified by the presence of the respective preoperative comorbidity: hypertension, hyperlipidemia, gastroesophageal reflux disease, sleep apnea, non-insulin-dependent diabetes, and insulin-dependent diabetes. A multinomial logistic regression model was used to predict 1-year remission (total, partial, or no remission) of insulin-dependent diabetes. All other outcomes were binary (yes or no at 1 yr), and ordinary logistic regression models were used | ||
| 520 | |a RESULTS: All models showed adequate discrimination (C statistics ranging from .58 to .68). Plots of observed versus predicted remission (%) showed excellent calibration across all models | ||
| 520 | |a CONCLUSION: All remission models were well calibrated with sufficient discrimination. The MBSAQIP Bariatric Surgical Risk/Benefit Calculator is a publicly available tool intended for integration into clinical practice to enhance patient-clinician discussions and informed consent | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 1-Year remission | |
| 650 | 4 | |a Bariatric surgery | |
| 650 | 4 | |a Benefits of bariatric surgery | |
| 650 | 4 | |a Calculator | |
| 650 | 4 | |a Comorbidity | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Gastroesophageal reflux disease (GERD) | |
| 650 | 4 | |a Hyperlipidemia | |
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Informed consent | |
| 650 | 4 | |a Long-term outcomes | |
| 650 | 4 | |a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) | |
| 650 | 4 | |a Multimorbidity | |
| 650 | 4 | |a Obesity-related disorder | |
| 650 | 4 | |a Postoperative comorbidity remission | |
| 650 | 4 | |a Shared decision-making | |
| 650 | 4 | |a Sleep apnea | |
| 650 | 7 | |a Insulins |2 NLM | |
| 700 | 1 | |a Huffman, Kristopher M |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen, Mark E |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, Bruce L |e verfasserin |4 aut | |
| 700 | 1 | |a Morton, John M |e verfasserin |4 aut | |
| 700 | 1 | |a Ko, Clifford Y |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery |d 2005 |g 20(2024), 3 vom: 31. März, Seite 275-282 |w (DE-627)NLM16493006X |x 1878-7533 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:3 |g day:31 |g month:03 |g pages:275-282 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.soard.2023.09.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 3 |b 31 |c 03 |h 275-282 | ||